Nektar Therapeutics


Nektar Therapeutics develops therapeutics based on its advanced polymer conjugate chemistry technology platform.

Industries

Employees

501-1,000

Links


Org chart

Howard Robin
President & CEO
Collapse
Jonathan Zalevsky
Chief Scientific Officer
Mark A. Wilson
SVP, General Counsel
Jennifer Ruddock
Senior Vice President & Chief Business Officer
Ken Franke
Senior Vice President, Biologics Development And Manufacturing
Jill Thomsen
SVP And Chief Financial Officer
Connie Louie-Tse
Executive Director
Wanda Allen
Data Mgmt Spec III
Lydia Falk
Executive Director
Robert Bacci
Chief People Officer & Head, Quality & Facilities

Board & advisors